ACTRN12611000466943招募中2 期
A pilot study to determine the optimal dose of esterified butyrate in patients with familial adenomatous polyposis
Commonwealth Scientific and Industrial Research Organisation (CSIRO) Preventative Health National Research Flagship0 个研究点目标入组 12 人开始时间: 2011年5月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •1. Age 18-75 years, male or female.
- •2. Generally in good health.
- •3. Patients with familial adenomatous polyposis with either ileorectal anastomosis or pouches.
- •4. Available for the duration of the study.
- •5. Willing to compy with faecal sample collection requirements.
排除标准
- •1. Intolerance to high-fibre products
- •2. Reported lactating, pregnant or wish to become pregnant during the study. If the volunteer becomes pregnant during the trial they will be withdrawn.
- •3. Person considered by the investigator to be unwilling, unlikely or unable to comprehend or comply with the study protocol and restrictions.
- •4. Recent or planned sureveillance endoscopy +/- bowel preparation within the trial period.
研究者
相似试验
尚未招募
不适用
A clinical study to determine the optimal dose of WIN-1001X by evaluating its efficacy and safety in patients with early Parkinson’s diseaseDiseases of the nervous systemKCT0004536Medihelpline188
进行中（未招募）
1 期
Phase II Clinical Trial to optimize the dose of an anti-NKG2A monoclonal antibody (humZ270 mAb, IPH2201) for patients with acute myeloid leukemia or myelodysplastic syndrome undergoing haploidentical transplantation with posttransplantation cyclophosphamide.Patients with acute myeloid leukemia or myelodysplastic syndrome undergoing haploidentical transplantation with posttransplantation cyclophosphamide.MedDRA version: 21.1Level: PTClassification code 10000880Term: Acute myeloid leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10028533Term: Myelodysplastic syndromeSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-005902-24-ITIRCCS ISTITUTO CLINICO HUMANITAS42
已完成
不适用
Designing physical activity interventional program for prediabetic populatioIRCT201607198132N4Vice chancellor for research of Tabriz University of Medical Sciences272
已完成
不适用
Clinical dose-finding study to assess the effect of ABAlifeTM on postprandial blood glucose profile in prediabetic subjects: randomized, multicentric, double-blind, placebo-controlled, cross-over study with different dosages combined with a 12-weeks follow-up phasePre-DiabetesDRKS00026093Anton Hübner GmbH & Co. KG61
已完成
1 期
Dose-escalation safety of novel fungal beta-glucanshealthy adult individualsbeta-GlucansPolysaccharidesOligosaccharidesFungiClinical TrialSafetyDietary SupplementsDose-escalation studyTCTR20240705004Institute of Nutrition, Mahidol University18